2Scandella D, Nakai H, Felch M, et al. In hemophilia A and antoantibody inhibitor patients: the factor Ⅷ A2 domain and light chain are most immunogenic. Thromb Ros, 2001,101 (5): 377-385.
3Meiklejohn DJ, Watson HG. Acquired haemophilia in association with organ special autoimmune disease. Haemophilia, 2001,7 (5) :523-525.
5Boggio LN, Green D. Acquired haemophilia. Rev Clin Exp Heamatol,2001,5(4) :389-404.
6Franchini M, Gandini G, Paolantonio TD, et al. Acquired Hemophilia A :A Concise Review. American J of Hematology,2005,80 (1) :55-63.
7Theodossiades G, Kontopoulou-Griva I. Acquired hemophilia A.Haematology ,2002,5 (4) :282-290.
8Lillicrap D, Nair SC, Srivestava A, et al. Laboratory issues in bleeding disorders. Haemophilia, 2006,12(3) :68-75.
9Di Bona E, Sehiavoni M, Castaman G, et al. Acquired haemophilia: experience of two Italian centres with 17 new cases. Haemophilia, 1997,3(3) :183-188.
10Giles AR, Verbruggen B, Rivard GE, et al. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor Ⅷ : C inhibitors in the haemophilia A population of Canada. Thromb Haemost, 1998,79(4) : 872-875.
二级参考文献23
1[1]Collins P, Maeartoey N, Davies R. et al. A population based, unselected, consecutive cohort of patients with acquired haemophilin A [J]. Br J Haematol,2004, 124:86～90.
2[2]Di Bona E,Schiavoni M,Castaman G,et al. Acquired hemophilia:experience of two inalian centers with 17 new cases[J]. Haemophilia,1997,3:183 ～ 188.
3[3]Huang YW,Saidi P,Philipp C. Acquired factor Ⅷ inhibitors in nonhaemophilic patients:clinical experience of 15 cases[J]. Haemophilia,2004,10:713～721.
4[4]Bossi P,Cabane J,Ninet J,et al. Acquired hemophilia due to factor Ⅷ inhibitors in 34 patients[J]. Am J Med, 1998,105:400 ～ 408.
5[5]Sallah S, Wan JY. Inhibitors against factor Ⅷ in patients with canceranalysis of 41 patients[J]. Cancer,2001,91:1067 ～ 1074.
6[6]Markris M, Hampton KK, Preston EE. Failure of recombinant F Ⅶ a treatment for abdominal bleeding in acquired hemophilia [J]. Am J Hematol,2001:66 ～ 67.
7[7]Guerin V, Chossat I, Dutronc H, et al. Recombinant F Ⅶ a in the treatment of bleeding in acquired hemophilia [J]. Am J Hematol,2002,70:333.
8[8]Baudo F, De Cataldo F. Acquired hemophilia: a critical bleeding syndrome[J]. Haemotologica. 2004,89(1) :96 ～ 100.
9[9]Morrison AE. Ludlam CA. Acquired haemophilia and its treatment [J]. Br J Haematol, 1995,89:231 ～ 236.
10[10]Baudo F,Mostarda G,De Cataldo F. Acquired factor Ⅷ and tactor Ⅸ inhibitors: survey of the inalian haemophilia centers( AICE). Reg ister of acquired Ⅷ/Ⅸ inhibitors. Haematologica[J]. 2003,88 ( Suppl) 12:93 ～ 99.
6Scandella D, Nakai H,Felch M, et al. In hemophilia A and autoanti- body inhibitor patients the factor V A2 domain and light chain are most immunogenic. Thromb Res ,2001,101 (5) :377-385.
7Collins PW, Hirsch S, Baglin TP, et al. Acquired hemophilia A in the United Kingdom : a 2-year national surveillance study by the U- nited Kingdom Haemophilia Centre Doctors' Organisation. Blood, 2007,109 ( 5 ) : 1870-1877.
8Delgado J,Jimenez-Yuste V, Hemandez-Navarro F,et al. Acquired haemophilia review and meta-analysis focuser on therapy and prog- nostic factors. Br J Haematol,2003,121 (1) :21-35.
9Franchini M, Gandini G, Di Paolantonio T,et al. Acquired hemo- philia A:a concise review. Am J Hematol,2005,80(1) :55-63.
10Dinichele DM. Inhibitor treatment in haemophilias A and B : inhibi- tor diagnosis. Haemophilia,2006,12(6) :37-42.
